Metabotropic glutamate receptor 5 (mGlu5) has been implicated in a variety of learning processes and is important for inhibitory avoidance and conditioned taste aversion learning. MGlu5 receptors are physically connected with NMDA receptors and they interact with, and modulate, the function of one another in several brain regions. The present studies used systemic co-administration of an mGlu5 receptor positive allosteric modulator, 3-cyano-N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamide (CDPPB) and an NMDA receptor antagonist dizocilpine maleate (MK-801) to characterize the interactions of these receptors in two aversive learning tasks. Male Sprague-Dawley rats were trained in a single-trial step-down inhibitory avoidance or conditioned taste aversion task. CDPPB (3 or 10 mg/kg, s.c.), delivered by itself prior to the conditioning trial, did not have any effect on performance in either task 48 h after training. However, CDPPB (at 3 mg/kg) attenuated the MK-801 (0.2 mg/kg, i.p.) induced learning deficit in both tasks. CDPPB also reduced MK-801-induced hyperactivity. These results underlie the importance of mGlu5 and NMDA receptor interactions in modulating memory processing, and are consistent with findings showing the efficacy of positive allosteric modulators of mGlu5 receptors in reversing the negative effects of NMDA receptor antagonists on other behaviors such as stereotypy, sensorimotor gating, or working, spatial and recognition memory.
Introduction
Glutamate, the major excitatory neurotransmitter in the adult central nervous system, acts through ionotropic (NMDA, AMPA, kainate) and metabotropic glutamate receptors (mGlus: group I, mGlu1 and mGlu5; group II, mGlu2 and mGlu3; group III, mGlu4, mGlu6, mGlu7 and mGlu8) (Niswender & Conn, 2010) . Recently, the interaction between group I mGlu and NMDA receptors on synaptic plasticity has received a great deal of attention. The functional interaction between mGlu5 and NMDA receptors has been studied at multiple levels from the molecular to the whole animal. However, although major progress has been made at the molecular and cellular levels, assessment of the effects of these interactions on cognitive functioning remains relatively unexplored.
Stimulation of mGlu5 receptor positively modulates the NMDA receptor through PKC phosphorylation and/or tyrosine kinase phosphorylation depending on the brain regions and specific conditions involved (Collett & Collingridge, 2004; Kotecha et al., 2003; Lu et al., 1999) . NMDA enhances mGlu5 receptor responses via calcineurin activation, which dephosphorylates the mGlu5 receptor at a PKC phosphorylation site (Alagarsamy et al., 1999) . The two receptors interact in a positive reciprocal manner, whereby stimulation of one receptor potentiates the function of the other. As individual synapses have specific signaling components, and different mGlu5 and NMDA receptor subtype/splice variants may be expressed, several mechanisms have been implicated in the upregulation of NMDA receptor functions by mGlu5 receptor and vice versa (Bruno et al., 2001; Hermans & Challiss, 2001) . The functional interactions between the two receptors are of widespread significance as these have been reported in the hippocampus, prefrontal cortex, striatum, subthalamic nucleus, nucleus accumbens and spinal cord (Attucci, Carla, Mannaioni, & Moroni, 2001; Awad, Hubert, Smith, Levey, & Conn, 2000; Fitzjohn et al., 1996; Kotecha et al., 2003; Mannaioni, Marino, Valenti, Traynelis, & Conn, 2001; Martin, Nie, & Siggins, 1997; Pisani et al., 2001; Ugolini, Corsi, & Bordi, 1997) . The two receptors physically link through anchoring proteins: mGlu5 receptor binds Homer proteins (Fagni, Ango, Perroy, & Bockaert, 2004) , NMDA receptor interacts with PSD-95, and Homer and PSD-95 can be clustered by Shank -a postsynaptic density protein (Naisbitt et al., 1999; Tu et al., 1999) . NMDA and mGlu5 receptors can act synergistically to activate a number of
